| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.023 | 0.9 |